...
首页> 外文期刊>Ultrasound in Medicine and Biology >Diagnostic Performance of Automated Breast Ultrasound as a Replacement for a Hand-Held Second-Look Ultrasound for Breast Lesions Detected Initially on Magnetic Resonance Imaging
【24h】

Diagnostic Performance of Automated Breast Ultrasound as a Replacement for a Hand-Held Second-Look Ultrasound for Breast Lesions Detected Initially on Magnetic Resonance Imaging

机译:自动乳房超声检查代替磁共振成像初步检测出的用于乳腺病变的手持式第二次超声检查的诊断性能

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the diagnostic performance of automated breast ultrasound (ABUS) after breast magnetic resonance imaging (MRI) as a replacement for hand-held second-look ultrasound (HH-SLUS), we evaluated 58 consecutive patients with breast cancer who had additional suspicious lesions on breast MRI. All patients underwent HH-SLUS and ABUS. Three breast radiologists evaluated the detectability, location, characteristics and conspicuity of lesions on ABUS. We also evaluated inter-observer variability and compared the results with HH-SLUS results. Eighty additional suspicious lesions were identified on breast MRI. Fifteen of the 80 lesions (19%) were not detected on HH-SLUS. Eight of the 15 lesions (53%) were detected on ABUS, whereas the remaining 7 were not detected on ABUS. Among the 65 lesions detected on HH-SLUS, only 3 lesions were not detected on ABUS. The intra-class correlation coefficients for lesion location and size all exceeded 0.70, indicating high reliability. Moderate to fair agreement was found for mass shape, orientation, margin and Breast Imaging Reporting and Data System (BI-RADS) final assessment. Therefore, ABUS can reliably detect additional suspicious lesions identified on breast MRI and may help in the decision on biopsy guidance method (US vs. MRI) as a replacement tool for HH-SLUS.
机译:为了评估乳房磁共振成像(MRI)替代手持式第二眼超声(HH-SLUS)后自动乳房超声(ABUS)的诊断性能,我们评估了58例患有其他可疑病变的连续性乳腺癌患者对乳房进行MRI检查。所有患者均接受了HH-SLUS和ABUS治疗。三名乳腺放射科医生评估了ABUS上病变的可检测性,位置,特征和显着性。我们还评估了观察者之间的差异,并将结果与​​HH-SLUS结果进行了比较。在乳腺MRI上发现了80个可疑病变。在HH-SLUS上未检测到80个病变中的15个(19%)。在15个病变中有8个(53%)在ABUS上检测到,而其余7个在ABUS上未检测到。在HH-SLUS上检测到的65个病变中,只有3个在ABUS上未检测到病变。病变位置和大小的类内相关系数均超过0.70,表明可靠性高。对于肿块的形状,方向,边缘和乳房成像报告和数据系统(BI-RADS)最终评估,发现程度适中。因此,ABUS能够可靠地检测出在乳房MRI上识别出的其他可疑病变,并可能有助于决定作为HH-SLUS的替代工具的活检指导方法(US vs. MRI)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号